The DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index.
Statins, cognition, and dementia-systematic review and methodological commentary
Open accessAbstract
Firm conclusions about whether mid-life or long-term statin use has an impact on cognitive decline and dementia remain elusive. Here, our objective was to systematically review, synthesize and critique the epidemiological literature that examines the relationship between statin use and cognition, so as to assess the current state of knowledge, identify gaps in our understanding, and make recommendations for future research. We summarize the findings of randomized controlled trials (RCTs) and observational studies, grouped according to study design. We discuss the methods for each, and consider likely sources of bias, such as reverse causation and confounding. Although observational studies that considered statin use at or near the time of dementia diagnosis suggest a protective effect of statins, these findings could be attributable to reverse causation. RCTs and well-conducted observational studies of baseline statin use and subsequent cognition over several years of follow-up do not support a causal preventative effect of late-life statin use on cognitive decline or dementia. Given that much of the human research on statins and cognition in the future will be observational, careful study design and analysis will be essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“statins have not been shown to prevent dementia (6, 7).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,762
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Research works printed but not linked: 1
- Carlsson, C. M. et al. Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. J. Alzheimers Dis. 13, 187–197 (2008). · DOI
Cited by
Sorted by citations
Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173
Newman, C. B., Preiss, D., Tobert, J. A., Jacobson, T. A., Page, R. L., II, Goldstein, L. B., Chin, C. C., Tannock, L. R., Miller, M. J., Raghuveer, G., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000073 · Cited by 790
Anstey, K. J., Ashby-Mitchell, K., & Peters, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160826 · Cited by 360
Mancini, G. B. J., Baker, S. K., Bergeron, J., FITCHETT, D. H., Frohlich, J. J., Genest, J. J., Gupta, M., Hegele, R. A., Ng, D. S., Pearson, G. J., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.01.003 · Cited by 257
Olmastroni, E., Molari, G., De Beni, N., Colpani, O., Galimberti, F., Gazzotti, M., Zambon, A., Catapano, A. L., & Casula, M. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab208 · Cited by 197
Ruscica, M., Ferri, N., Banach, M., Sirtori, C. R., & Corsini, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac020 · Cited by 218
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
Geifman, N., Brinton, R. D., Kennedy, R. E., Schneider, L. S., & Butte, A. J. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0237-y · Cited by 191
Association of midlife lipids with 20‐year cognitive change: A cohort study
Power, M. C., Rawlings, A. M., Sharrett, A. R., Bandeen‐Roche, K., Coresh, J., Ballantyne, C. M., Pokharel, Y., Michos, E. D., Penman, A. D., Alonso, Á., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.07.757 · Cited by 151
Self-citationStatins and Inflammation: New Therapeutic Opportunities in Psychiatry
Kim, S., Kang, H., Jhon, M., Kim, J., Lee, J., Walker, A. J., Agustini, B., Kim, J., & Berk, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00103 · Cited by 142
Meat consumption and risk of incident dementia: cohort study of 493,888 UK Biobank participants
Zhang, H., Greenwood, D. C., Risch, H. A., Bunce, D. J., Hardie, L. J., & Cade, J. E. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab028 · Cited by 135
Schilling, S., Tzourio, C., Soumaré, A., Kaffashian, S., Dartigues, J., Ancelin, M., Samieri, C., Dufouil, C., & Debette, S. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002265 · Cited by 121
Arterial stiffness, cognitive impairment and dementia: confounding factor or real risk?
Iulita, M. F., de la Colina, A. N., & Girouard, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14235 · Cited by 109
Separable Effects for Causal Inference in the Presence of Competing Events
Stensrud, M. J., Young, J. G., Didelez, V., Robins, J. M., & Hernán, M. Á. (2020) · Journal of the American Statistical Association · doi:10.1080/01621459.2020.1765783 · Cited by 104
Antiaging agents: safe interventions to slow aging and healthy life span extension
Liu, J. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00339-y · Cited by 112
Larsson, S. C., & Markus, H. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180288 · Cited by 100
Goldstein, L. B., Toth, P. P., Dearborn, J. L., Giugliano, R. P., Hirsh, B. J., Peña, J. M., Selim, M. H., & Woo, D. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000164 · Cited by 99
PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016
Banach, M., Jankowski, P., Jóźwiak, J., Cybulska, B., Windak, A., Guzik, T., Mamcarz, A., Broncel, M., & Tomasik, T. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.64712 · Cited by 86
Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
Alsubaie, N., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alharbi, B., WAARD, M. M. D., Sabatier, J., Saad, . M., & Batiha, G. E. (2022) · Brain Sciences · doi:10.3390/brainsci12101290 · Cited by 87
Joseph, J., Pajewski, N. M., Dolor, R. J., Sellers, M. A., Perdue, L., Peeples, S. R., Henrie, A. M., Woolard, N., Jones, W. S., Benziger, C. P., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18312 · Cited by 91
Effects of blood pressure and lipid lowering on cognition
Bosch, J., O'Donnell, M. J., Swaminathan, B., Lonn, E., Sharma, M., Dagenais, G. R., Díaz, R., Khunti, K., Lewis, B. S., Avezum, Á., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007174 · Cited by 87
Mayeda, E. R., Tchetgen, E. J. T., Power, M. C., Weuve, J., Jacqmin‐Gadda, H., Marden, J. R., Vittinghoff, E., Keiding, N., & Glymour, M. M. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv451 · Cited by 82
Self-citationYang, Z., Wang, H., Edwards, D., Ding, C., Yan, L., Brayne, C., & Mant, J. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100962 · Cited by 79
Physical and Mental Activity, Disease Susceptibility, and Risk of Dementia
Zhu, J., Ge, F., Zeng, Y., Qu, Y., Chen, W., Yang, H., Yang, L., Fang, F., & Song, H. (2022) · Neurology · doi:10.1212/wnl.0000000000200701 · Cited by 77
Petek, B., Häbel, H., Xu, H., Villa-Lopez, M., Kalar, I., Hoang, M. T., Maioli, S., Pereira, J. B., Mostafaei, S., Winblad, B., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01360-0 · Cited by 65
Statins and cognition: Modifying factors and possible underlying mechanisms
Jamshidnejad-Tosaramandani, T., Kashanian, S., Al-Sabri, M. H., Kročianová, D., Clemensson, L. E., Gentreau, M., & Schiöth, H. B. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.968039 · Cited by 60
Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment
Pépin, M., Klimkowicz‐Mrowiec, A., Godefroy, O., Delgado, P., Carriazo, S. M., Ferreira, A. C., Golenia, A., Małyszko, J., Grodzicki, T. K., Giannakou, K., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15928 · Cited by 66
Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs
Hoyos, P., Pace, V., & Alcántara, A. R. (2019) · Catalysts · doi:10.3390/catal9030260 · Cited by 61
Emulating a target trial of statin use and risk of dementia using cohort data
Caniglia, E. C., Rojas-Saunero, L. P., Hilal, S., Licher, S., Logan, R., Stricker, B., Ikram, M. A., & Swanson, S. A. (2020) · Neurology · doi:10.1212/wnl.0000000000010433 · Cited by 56
Developmental and extrahepatic physiological functions of SREBP pathway genes in mice
Engelking, L. J., Cantoria, M. J., Xu, Y., & Liang, G. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.07.011 · Cited by 56
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Zhao, X., Zhang, S., Sanders, A. R., & Duan, J. (2023) · Complex Psychiatry · doi:10.1159/000535131 · Cited by 54
Adhikari, A., Tripathy, S., Chuzi, S., Peterson, J., & Stone, N. J. (2021) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2020.10.007 · Cited by 52
Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications
Chopard, R., Piazza, G., Gale, S. A., Campia, U., Albertsen, I. E., Kim, J., & Goldhaber, S. Z. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.06.035 · Cited by 50
Association Between Statin Use and Risk of Dementia After a Concussion
Redelmeier, D. A., Manzoor, F., & Thiruchelvam, D. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.1148 · Cited by 49
Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus
Tan, E. C. K., Sluggett, J. K., Johnell, K., Onder, G., Elseviers, M. M., Morin, L., Vetrano, D. L., Wastesson, J. W., Fastbom, J., Taipale, H. T., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.12.002 · Cited by 46
Pharmacological interventions for cognitive decline in people with Down syndrome
Livingstone, N., Hanratty, J., McShane, R. H., & Macdonald, G. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011546.pub2 · Cited by 44
Petek, B., Villa‐Lopez, M., Loera‐Valencia, R., Gereñu, G., Winblad, B. G., Kramberger, M. G., Ismail, M. A. M., Eriksdotter, M., & Ptacek, S. G. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12838 · Cited by 47
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
Boyce, G. K., Button, E. B., Sonja, S. V., & Wellington, C. L. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160103 · Cited by 41
Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trial
Eymard, F., Parsons, C. M., Edwards, M. H., Petit-Dop, F., Reginster, J., Bruyère, O., Chevalier, X., Cooper, C. C., & Richette, P. (2017) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.09.014 · Cited by 39
Comparative effect of statins on the risk of incident Alzheimer disease
Sinyavskaya, L., Gauthier, S. G., Renoux, C., Dell’Aniello, S., Suissa, S., & Brassard, P. (2017) · Neurology · doi:10.1212/wnl.0000000000004818 · Cited by 40
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)
Kolson, D. L. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00612-2 · Cited by 42
The Cognitive Effects of Statins are Modified by Age
Alsehli, A. M., Olivo, G., Clemensson, L. E., Williams, M. J., & Schiöth, H. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-63035-2 · Cited by 38
Effects of Plasma Lipids and Statins on Cognitive Function
Li, R., Wang, T., Lyu, P., Liu, Y., Chen, W., Fan, M., & Xu, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.225062 · Cited by 40
Statins and Brain Health: Alzheimer’s Disease and Cerebrovascular Disease Biomarkers in Older Adults
Ramanan, V. K., Przybelski, S. A., Graff‐Radford, J., Castillo, A. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Reid, R. I., Knopman, D. S., Jack, C. R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180446 · Cited by 36
Xu, C., Apostolova, L. G., Oblak, A. L., & Gao, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191023 · Cited by 35
Rajan, K. B., Mcaninch, E. A., Wilson, R. S., Dhana, A., Evans-Lacko, S., & Evans, D. A. (2024) · Neurology · doi:10.1212/wnl.0000000000209168 · Cited by 34
Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study
Marcum, Z. A., Walker, R. L., Bobb, J. F., Sin, M., Gray, S. L., Bowen, J. D., McCormick, W. C., McCurry, S. M., Crane, P. K., & Larson, E. B. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15581 · Cited by 38
Trials and Treatments for Vascular Brain Health: Risk Factor Modification and Cognitive Outcomes
Kivipelto, M., Palmer, K., Hoang, T. D. M., & Yaffe, K. S. (2022) · Stroke · doi:10.1161/strokeaha.121.032614 · Cited by 35
Arıkan, İ., Metintaş, S., Kalyoncu, C., & Yıldız, Z. (2009) · PubMed · Cited by 39
Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort
Mecca, A. P., Michalak, H. R., McDonald, J. W., Kemp, E. C., Pugh, E., Becker, M. L., Mecca, M. C., van Dyck, C. H., & (ADNI), T. A. D. N. I. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000488671 · Cited by 33
Cholesterol and Dementia: A Long and Complicated Relationship
McFarlane, O., & Kędziora–Kornatowska, K. (2019) · Current Aging Science · doi:10.2174/1874609812666190917155400 · Cited by 33
Separable Effects for Causal Inference in the Presence of Competing Events
Stensrud, M. J., Young, J. G., Didelez, V., Robins, J. M., & Hernán, M. Á. (2020) · Figshare · doi:10.6084/m9.figshare.12312236 · Cited by 29
Statin use and safety concerns: an overview of the past, present, and the future
Mulchandani, R., Lyngdoh, T., & Kakkar, A. K. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1796966 · Cited by 29
Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta‐Analysis
Davis, K. A. S., Bishara, D., Perera, G., Molokhia, M., Rajendran, L., & Stewart, R. J. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16342 · Cited by 28
Desai, R. J., Varma, V. R., Gerhard, T., Segal, J. B., Mahesri, M., Chin, K., Nonnenmacher, E., Gabbeta, A., Oommen, A. M., Varma, S., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12095 · Cited by 26
Plasma sphingolipids and depressive symptoms in coronary artery disease
Dinoff, A., Saleem, M., Herrmann, N., Mielke, M. M., OH, P. I., Venkata, S. L. V., Haughey, N. J., & Lanctôt, K. L. (2017) · Brain and Behavior · doi:10.1002/brb3.836 · Cited by 27
Statin Use and Risk of Cognitive Decline in the ADNI Cohort
Kemp, E. C., Ebner, M. K., Ramanan, S., Godek, T. A., Pugh, E., Bartlett, H. H., McDonald, J. W., Mecca, M. C., van Dyck, C. H., & Mecca, A. P. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.11.003 · Cited by 25
Antiaging Therapies, Cognitive Impairment, and Dementia
Wahl, D., Anderson, R. M., & Couteur, D. G. L. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz135 · Cited by 25
Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective
Shang, G., Shao, Q., Lv, K., Xu, W., Ji, J., Fan, S., Kang, X., Cheng, F., Wang, X., & Wang, Q. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01217-3 · Cited by 24
Pharmacological interventions for cognitive decline in people with Down syndrome
Livingstone, N., Hanratty, J., Macdonald, G., & McShane, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011546 · Cited by 24
Kostis, J. B., Giakoumis, M., Zinonos, S., Cabrera, J., & Kostis, W. J. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.020 · Cited by 23
Hu, W., Li, Y., Zhao, Y., Dong, Y., Cui, Y., Sun, S., Gong, G. X., Zhang, H., Chai, Q., Wang, J., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00154 · Cited by 23
The heart–brain connection: from evidence to action
Roger, V. L. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx387 · Cited by 22
Gentreau, M., Rukh, G., Miguet, M., Clemensson, L. E., Alsehli, A. M., Titova, O. E., & Schiöth, H. B. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad163 · Cited by 23
Kern, D. M., Cepeda, M. S., Lovestone, S., & Seabrook, G. R. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.07.012 · Cited by 21
Shen, L., Dewan, P., Ferreira, J. P., Cunningham, J. W., Jhund, P. S., Anand, I. S., Chandra, A., Chiang, L., Claggett, B. L., Desai, A. S., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.070553 · Cited by 23
Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence
Kazibwe, R., Rikhi, R. R., Mirzai, S., Ashburn, N. P., Schaich, C. L., & Shapiro, M. D. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01255-x · Cited by 20
Yang, Z., Toh, S., Li, X., Edwards, D., Brayne, C., & Mant, J. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00856-7 · Cited by 19
Virk, D., Kumar, A., Jaggi, A. S., & Singh, N. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15189-3 · Cited by 19
Tiwari, N., Bhatia, P., Kumar, A., Jaggi, A. S., & Singh, N. (2018) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12376 · Cited by 18
Wang, W., Zhang, L., Xia, K., Huang, T., & Fan, D. (2023) · Biomedicines · doi:10.3390/biomedicines11051359 · Cited by 17
Zahedi, E., Sanaeierad, A., Nikbakhtzadeh, M., Roghani, M., & Zamani, E. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114611 · Cited by 16
Association of statins use and genetic susceptibility with incidence of Alzheimer's disease
Ye, Z., Deng, J., Wu, X., Cai, J., Li, S., Chen, X., & Xin, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100025 · Cited by 17
Preventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome
Ahmad, M. I., & Shapiro, M. D. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00913-8 · Cited by 14
Xiao, M., Li, L., Zhu, W., Wu, F., & Wu, B. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2311875 · Cited by 14
Drug interactions with dementia‐related pathophysiological pathways worsen or prevent dementia
Barus, R., Béné, J., Deguil, J., Gautier, S., & Bordet, R. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14607 · Cited by 12
Grasset, L., Smit, R. A. J., Caunca, M. R., Elfassy, T., Odden, M. C., van der Grond, J., van Buchem, M. A., Stott, D. J., Sattar, N. A., Trompet, S., et al. (2020) · Journal of Aging and Health · doi:10.1177/0898264320916959 · Cited by 13
Paiva, I., Séguin, J., Grgurina, I., Singh, A. K., Cosquer, B., Plassard, D., Tzeplaeff, L., Gras, S. L., Cotellessa, L., Decraene, C., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106538 · Cited by 12
Kim, J. H., Lee, H. S., Wee, J. H., Kim, Y. H., Min, C., Yoo, D. M., & Choi, H. G. (2021) · Brain Sciences · doi:10.3390/brainsci11030396 · Cited by 11
Statin Therapy and Dementia in Older Adults: Role of Disease Severity and Multimorbidity
Gnjidic, D., Fastbom, J., Fratiglioni, L., Rizzuto, D., Angleman, S. B., & Johnell, K. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13907 · Cited by 11
Anstey, K. J., & Peters, R. (2018) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2017.27 · Cited by 10
“If high cholesterol in late-life is not a risk factor for dementia, then trials of statins to prevention dementia are not indicated, and indeed, statins have not been shown to prevent dementia (6, 7).”
Primary Prevention Statins in Older Adults: Personalized Care for a Heterogeneous Population
O'Neill, D., Stone, N. J., & Forman, D. E. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16330 · Cited by 10
Cognitive function in dyslipidemia patients: exploring the impact of statins
Wang, W., & Li, X. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1436010 · Cited by 9
Leisure-Time Television Viewing and Computer Use, Family History, and Incidence of Dementia
Zhuang, Z., Zhao, Y., Song, Z., Wang, W., Huang, N., Dong, X. Y., Xiao, W., Li, Y., Jia, J., Liu, Z., et al. (2023) · Neuroepidemiology · doi:10.1159/000531237 · Cited by 9
Lü, Z., Cai, Y., Qiu, B., Lan, L., Lin, J., & Fan, Y. (2020) · BioMed Research International · doi:10.1155/2020/4864017 · Cited by 9
The Impact of Sex‐Specific Survival on the Incidence of Dementia in Parkinson's Disease
Fink, A., Dodel, R. C., Georges, D., & Doblhammer, G. (2023) · Movement Disorders · doi:10.1002/mds.29596 · Cited by 8
Bénéfices et risques des statines en prévention primaire chez la personne âgée
Joseph, J.-P., Afonso, M., Berdaï, D., Salles, N., Bénard, A., Gay, B., & Bonnet, F. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.09.015 · Cited by 8
Pal, L., Morgan, K. N., Santoro, N. F., Manson, J. E., Taylor, H. S., Miller, V. M., Brinton, E. A., Løbo, R. A., Neal-Perry, G. S., Cedars, M. I., et al. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.04.004 · Cited by 10
Harding, I. H., Ryan, J. L., Heritier, S. R., Spark, S., Flanagan, Z., McIntyre, R., Anderson, C. S., Naismith, S. L., Chong, T. T. ‐., O'Sullivan, M. J., et al. (2023) · BMJ Neurology Open · doi:10.1136/bmjno-2023-000541 · Cited by 9
Turan, T. N., Kasab, S. A., Smock, A., Cotsonis, G., Bachman, D., Lynn, M., Nizam, A., Derdeyn, C. P., Fiorella, D., Janis, S., et al. (2019) · Cerebrovascular Diseases · doi:10.1159/000497245 · Cited by 7
Hazzouri, A. Z. A., Jawadekar, N., Grasset, L., Kaiser, P., Kezios, K., Calónico, S., Glymour, M. M., Hirsch, C. H., Arnold, A. M., Varadhan, R., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab220 · Cited by 7
Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020
Zimmerman, S. C., Choi, M., Jiang, C., Ferguson, E. L., Hoffmann, T. J., Swinnerton, K. N., Oni‐Orisan, A., Gilsanz, P., Meyers, T. J., Choudhary, V., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213855 · Cited by 8
APOE4 poses opposite effects of plasma LDL on white matter integrity in older adults
Ye, Z., Pan, Y., McCoy, R. G., Bi, C., Mo, C., Feng, L., Yu, J., Lu, T., Liu, S., Smith, J. C., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.08.005 · Cited by 7
Clough, A. J., Hilmer, S. N., Naismith, S. L., & Gnjidic, D. (2019) · Healthcare · doi:10.3390/healthcare7040161 · Cited by 6
Statin use and risk of Alzheimer disease
Yaşar, S., & Whitmer, R. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004837 · Cited by 6
Alsehli, A. M., Rukh, G., Clemensson, L. E., Ciuculete, D. M., Tan, X. W., Al-Sabri, M. H., Williams, M. J., Benedict, C., & Schiöth, H. B. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5039 · Cited by 5
Acute myocardial infarction is associated with faster age-related cognitive decline
Liuzzo, G., & Patrono, C. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad475 · Cited by 5
Statin use and cognitive function in middle-aged adults with type 1 diabetes
Nunley, K. A., Orchard, T. J., Ryan, C. M., Miller, R. G., Costacou, T., & Rosano, C. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.286 · Cited by 5
Statin therapy reduces dementia risk in atrial fibrillation patients receiving oral anticoagulants
Kim, M. H., Yuan, S. L., Lee, K. M., Jin, X. S., Song, Z. Y., Park, J. S., Cho, Y., Lim, K., Yun, S., Lee, M. S., et al. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad039 · Cited by 6
Rossi, R., Nouri, A., Akman, Z., Nezhad, S. A., Damluji, A. A., & Nanna, M. G. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02329-1 · Cited by 5
Hinwood, M., Nyberg, J., Leigh, L., Gustavsson, S., Attia, J., Oldmeadow, C. J., Ilicic, M., Linden, T. K. A., Åberg, N. D., Levi, C. R., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058244 · Cited by 4
Metadata
- Authors
- Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F.
- Affiliations
- Johns Hopkins University (US)
- Rush University Medical Center (US)
- Harvard University (US)
- Corresponding author
- Gottesman, Rebecca F.
- Venue
- Nature Reviews Neurology
- Published
- 2015-03-24
- Volume
- 11
- Issue
- 4
- Pages
- 220-229
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC4458855
- OpenAlex
- W2075092696
- Cited by
- 150
- References
- 100
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 15 · 2023: 20 · 2022: 11 · 2021: 9 · 2020: 15 · 2019: 14 · 2018: 15 · 2017: 19 · 2016: 7 · 2015: 5
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Alzheimer's Drug Discovery Foundation
- National Institute on Aging (P50AG005134, T32AG027668, P30AG062421)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- statins, cognitive decline, dementia, Alzheimer's disease, cognitive impairment, reverse causality, confounding, observational study design, randomized controlled trials
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cognition Disorders, Dementia, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
